His scientific interests lie mostly in Internal medicine, Endocrinology, Nitric oxide synthase, Nitric oxide and Fibrosis. His Internal medicine study frequently links to adjacent areas such as Placebo. His work on Nitrotyrosine as part of general Nitric oxide research is often related to Peroxynitrite, thus linking different fields of science.
The Fibrosis study which covers Vardenafil that intersects with Denervation. His research integrates issues of Diabetes mellitus and Penis in his study of Erectile dysfunction. His biological study spans a wide range of topics, including Fibroblast and Peyronie's disease.
His primary areas of study are Internal medicine, Endocrinology, Erectile dysfunction, Fibrosis and Nitric oxide. Internal medicine is closely attributed to Urology in his study. Jacob Rajfer combines topics linked to Agonist with his work on Endocrinology.
His Erectile dysfunction course of study focuses on Penis and Pharmacology. His Fibrosis research focuses on Peyronie's disease and how it connects with Tunica albuginea. His study in Nitric oxide is interdisciplinary in nature, drawing from both Wound healing, Phosphodiesterase, cGMP-specific phosphodiesterase type 5 and Western blot.
Internal medicine, Erectile dysfunction, Endocrinology, Fibrosis and Urology are his primary areas of study. Jacob Rajfer regularly links together related areas like Cardiology in his Internal medicine studies. His research in the fields of Tadalafil overlaps with other disciplines such as Phosphodiesterase 5 inhibitor.
His Endocrinology study combines topics in areas such as Immunohistochemistry, Terminal deoxynucleotidyl transferase, TUNEL assay and Histopathology. The Fibrosis study combines topics in areas such as Sildenafil, Hydroxyproline, Nitric oxide synthase and Stem cell. His work carried out in the field of Nitric oxide brings together such families of science as cGMP-specific phosphodiesterase type 5 and Pharmacology.
Jacob Rajfer spends much of his time researching Fibrosis, Internal medicine, Endocrinology, Nitric oxide synthase and Erectile dysfunction. Jacob Rajfer has researched Fibrosis in several fields, including Transforming growth factor beta, Circulatory system and Lumen. His Anatomy research extends to the thematically linked field of Internal medicine.
Jacob Rajfer combines subjects such as Sildenafil, Angiogenesis and CTGF with his study of Endocrinology. His work deals with themes such as Terminal deoxynucleotidyl transferase and TUNEL assay, which intersect with Nitric oxide synthase. His work on Tadalafil as part of general Erectile dysfunction study is frequently connected to Phosphodiesterase 5 inhibitor, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission
Jacob Rajfer;William J. Aronson;Peggy A. Bush;Frederick J. Dorey.
The New England Journal of Medicine (1992)
Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle
Louis J. Ignarro;Peggy A. Bush;Georgette M. Buga;Keith S. Wood.
Biochemical and Biophysical Research Communications (1990)
Sildenafil for Treatment of Erectile Dysfunction in Men With Diabetes: A Randomized Controlled Trial
Marc S. Rendell;Jacob Rajfer;Pierre A. Wicker;Michael D. Smith.
JAMA (1999)
Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial.
Daniel A Shoskes;Scott I Zeitlin;Asha Shahed;Jacob Rajfer.
Urology (1999)
Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the rat.
J A Lugg;J Rajfer;N F González-Cadavid.
Endocrinology (1995)
VARDENAFIL PREVENTS FIBROSIS AND LOSS OF CORPORAL SMOOTH MUSCLE THAT OCCURS AFTER BILATERAL CAVERNOSAL NERVE RESECTION IN THE RAT
Monica G. Ferrini;Monica G. Ferrini;Hugo H. Davila;Istvan Kovanecz;Sandra P. Sanchez.
Urology (2006)
Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum.
Peggy A. Bush;William J. Aronson;Georgette M. Buga;Jacob Rajfer.
The Journal of Urology (1992)
L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures.
Eliane G.A Valente;Dolores Vernet;Monica G Ferrini;Ansha Qian.
Nitric Oxide (2003)
Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction.
Dolores Vernet;Liping Cai;Hermes Garban;Martha L. Babbitt.
Endocrinology (1995)
Peyronie's Disease: A Review.
Shahram S. Gholami;Nestor F. Gonzalez-Cadavid;Ching-Shwun Lin;Jacob Rajfer.
The Journal of Urology (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, Los Angeles
Los Angeles Biomedical Research Institute
Cedars-Sinai Medical Center
University of California, Los Angeles
University of California, Los Angeles
University of California, Los Angeles
Johns Hopkins University School of Medicine
Brigham and Women's Hospital
Vanderbilt University Medical Center
New York University
Inserm : Institut national de la santé et de la recherche médicale
Publications: 33
Vrije Universiteit Amsterdam
Polytechnic University of Turin
Chalmers University of Technology
The University of Texas at Austin
Nankai University
University of California, Santa Barbara
University of Burgundy
University of Cambridge
University of Leeds
National Oceanic and Atmospheric Administration
Cleveland Clinic
Mayo Clinic
Duke University
University of Glasgow
Bocconi University
University of Cincinnati